Item 15. Exhibit and Financial Statement Schedules

**(a)**The following documents are filed as part of this report:

(1) Financial Statements:


			Page(s)
Report of Independent Registered Public Accounting Firm — PricewaterhouseCoopers LLP			58
Consolidated Statement of Income for the three years ended December 31, 2022			60
Consolidated Statement of Comprehensive Income for the three years ended December 31, 2022			61
Consolidated Balance Sheet at December 31, 2022 and 2021			62
Consolidated Statement of Cash Flows for the three years ended December 31, 2022			63
Consolidated Statement of Equity for the three years ended December 31, 2022			64
Notes to the Consolidated Financial Statements			65 to 98

(2) Financial Statement Schedules:

Included below is Schedule II - Valuation and Qualifying Accounts for each of the three years in the period ended December 31, 2022.

(3) Exhibits:

The Exhibit Index on the following pages lists the exhibits that are filed as part of this report.

Schedule II — Valuation and Qualifying Accounts


	Year ended December 31
Millions of Dollars	2022		2021		2020
Employee Termination Benefits
Balance at January 1	$	43	$	470	$	7
Additions (reductions) charged to expense	1		(30)		859
Payments	(33)		(397)		(396)
Balance at December 31	$	11	$	43	$	470
Expected Credit Losses
Beginning allowance balance for expected credit losses	$	745	$	671	$	849
Current period provision	263		74		573

Write-offs charged against the allowance, if any	—		—		(751)

Balance at December 31	$	1,008	$	745	$	671
Deferred Income Tax Valuation Allowance1
Balance at January 1	$	17,651	$	17,762	$	15,965
Additions to deferred income tax expense2	3,533		3,691		2,892
Reduction of deferred income tax expense	(1,652)		(3,802)		(1,095)
Balance at December 31	$	19,532	$	17,651	$	17,762

2 Includes $974 of additions associated with the purchase of Noble in 2020.